Nyrada (ASX:NYR) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Nyrada and 138267 (COM.TO), as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Nyrada | 0 | 0 | 0 | 0 | N/A |
138267 (COM.TO) | 0 | 0 | 0 | 0 | N/A |
Profitability
This table compares Nyrada and 138267 (COM.TO)'s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Nyrada | N/A | N/A | N/A |
138267 (COM.TO) | N/A | N/A | N/A |
Valuation & Earnings
This table compares Nyrada and 138267 (COM.TO)'s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Nyrada | $1.18 million | 0.00 | C$-6,317,082.00 | A($0.06) | N/A |
138267 (COM.TO) | N/A | N/A | N/A | N/A | N/A |
138267 (COM.TO) has lower revenue, but higher earnings than Nyrada.
Summary
Nyrada beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.